Stockscreener 앱 받기
16.99
0.18%
0.03
전일 마감가:
$16.96
열려 있는:
$16.92
하루 거래량:
179.30K
Relative Volume:
0.42
시가총액:
$1.05B
수익:
-
순이익/손실:
$-41.43M
주가수익비율:
-21.51
EPS:
-0.79
순현금흐름:
$-39.97M
1주 성능:
+13.19%
1개월 성능:
+34.20%
6개월 성능:
-1.74%
1년 성능:
+97.56%
1일 변동 폭
$16.55
$17.20
1주일 범위
$14.75
$17.33
52주 변동 폭
$7.98
$20.50
Gh Research Plc Stock (GHRS) Company Profile
GHRS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
16.99 | 1.05B | 0 | -41.43M | -39.97M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-13 | 개시 | Needham | Buy |
| 2025-06-04 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-03-13 | 개시 | Guggenheim | Buy |
| 2025-03-07 | 개시 | RBC Capital Mkts | Outperform |
| 2025-02-13 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-08-16 | 개시 | H.C. Wainwright | Buy |
| 2022-06-16 | 개시 | ROTH Capital | Buy |
모두보기
Gh Research Plc 주식(GHRS)의 최신 뉴스
GH Research (GHRS) Is Up 9.1% After FDA Lifts Clinical Hold On GH001 Depression Drug - simplywall.st
Aug Setups: Whats the profit margin of GH Research PLCJuly 2025 Fed Impact & Precise Entry and Exit Recommendations - baoquankhu1.vn
What is the dividend yield of GH Research PLCPortfolio Update Report & Long-Term Capital Growth Ideas - baoquankhu1.vn
CEO Change: Is GH Research PLC a turnaround story2025 Market WrapUp & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Is GH Research PLC stock undervalued right now2025 Key Highlights & Weekly High Momentum Picks - bollywoodhelpline.com
Aug Setups: Is GH Research PLC stock supported by strong fundamentalsJuly 2025 Summary & Verified Entry Point Detection - Bộ Nội Vụ
GH Research Showcases Positive GH001 Phase 2b Data in Treatment-Resistant Depression at ACNP 2026 - TipRanks
How FDA’s Lifted Clinical Hold On GH001 At GH Research (GHRS) Has Changed Its Investment Story - Yahoo Finance
Responsive Playbooks and the GHRS Inflection - Stock Traders Daily
EBIT per share of GH Research Plc – FWB:1KA - TradingView — Track All Markets
GH Research PLC (GHRS) Stock Analysis: 109.70% Upside Potential Amid Promising Biotech Innovations - DirectorsTalk Interviews
Wall Street Analysts Think GH Research (GHRS) Could Surge 130.59%: Read This Before Placing a Bet - MSN
Will GH Research PLC (1KA) stock profit from fiscal stimulusStability vs Neutral Overview & lightweight options for faster days - Улправда
Dow Jumps 800 Points; ISM Manufacturing PMI Falls In December - Sahm
Assessing GH Research (GHRS) Valuation After FDA Lifts Clinical Hold On GH001 IND - Sahm
Is GH Research PLC (1KA) stock protected from inflationTrade Ideas & Low Risk Entry Point Tips - Улправда
Why analysts maintain buy rating on GH Research PLC (1KA) stock2025 Market Overview & Low Risk Profit Maximizing Plans - Улправда
Risk Analysis: How institutional buying supports GH Research PLC stockTrend Reversal & High Accuracy Investment Entry Signals - ulpravda.ru
Published on: 2026-01-09 02:32:55 - Улправда
GH Research PLCOrdinary Shares (NQ: GHRS - FinancialContent
What dividend safety score for GH Research PLC stockEarnings Risk Report & Low Risk High Reward Trade Ideas - ulpravda.ru
How strong is GH Research PLC stock balance sheet2025 Valuation Update & Weekly High Conviction Ideas - Улправда
Quarterly Recap: What dividend safety score for GH Research PLC stock2025 Top Gainers & Weekly High Conviction Trade Ideas - Улправда
GH Research to Present Six-Month Safety and Efficacy Data on Inhaled GH001 in Depression at 2026 ACNP Meeting - TipRanks
Why is GHRS stock rising today? - MSN
Assessing GH Research (GHRS) Valuation After FDA Lifts Clinical Hold On GH001 Trials - Yahoo Finance
Stock market today: S&P 500, Nasdaq futures rise, WTI fluctuates following US strike on Venezuela—GH Research, Vertiv Holdings, Nukkleus in focus - MSN
Why Is GHRS Stock Rising Today? - Asianet Newsable
GH Research Stock Grabs Retail Spotlight Ahead Of FDA Update On Depression Treatment - Asianet Newsable
What drives GH Research PLC stock priceDividend Reinvestment Plans & Outstanding Capital Tips - earlytimes.in
GH Research (NASDAQ:GHRS) Stock Price Up 6.9%Should You Buy? - MarketBeat
Will GH Research PLC (1KA) stock gain from green policies2026 world cup usa national team round of 32 playmakers pressing system odds analysis tactical review - Улправда
GH Research (NASDAQ:GHRS) Stock Price Down 9.2%Should You Sell? - MarketBeat
GH Research stock price target raised to $29 from $19 at Needham - Investing.com Nigeria
GH Research stock jumps as Canaccord raises price target on FDA hold lift - Investing.com Nigeria
GH Research stock price target raised to $29 from $19 at Needham By Investing.com - Investing.com South Africa
GH Research stock rises as FDA lifts clinical hold on GH001 By Investing.com - Investing.com South Africa
GH Research stock jumps as Canaccord raises price target on FDA hold lift By Investing.com - Investing.com South Africa
GH Research stock rises as FDA lifts clinical hold on GH001 - Investing.com Australia
GHRS Stock Sees Significant Price Target Increase by Needham | G - GuruFocus
GH Research (GHRS) Is Up 24.2% After FDA Lifts Hold On GH001 U.S. Trial Enrollment - simplywall.st
Hold lifted, as GH Research preps for pivotal GH-001 depression trial - BioWorld MedTech
GH Research stock rating reiterated as Buy by TD Cowen - Investing.com South Africa
GH Research says FDA lifts clinical hold on GH001 - TipRanks
GH Research stock rises as FDA lifts clinical hold on inhaled 5-MeO-DMT By Investing.com - Investing.com South Africa
GH Research (NASDAQ:GHRS) Shares Gap UpTime to Buy? - MarketBeat
GH Research stock rises as Stifel reiterates Buy rating after clinical hold lifted By Investing.com - Investing.com South Africa
GH Research stock rises as FDA lifts clinical hold on inhaled 5-MeO-DMT - Investing.com Nigeria
Altimmune, GH Research, Gyre Therapeutics And Other Big Stocks Moving Higher On Monday - Benzinga
Gh Research Plc (GHRS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):